Atlas Trials

PET Study to Study Tumour Apoptosis

Clinical trial NCT01428440 · TERMINATED

Trial details

NCT number
NCT01428440
Sponsor
GlaxoSmithKline
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Cancer
Start date
2009-12-01
Primary completion
2011-07-01
Enrollment
7

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.